Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.

Masafumi Ono; Rutao Wang; Hideyuki Kawashima; Chao Gao; Rutao Wang; Joanna J. Wykrzykowska; Jan J. Piek; Scot Garg; Christian W. Hamm; Philippe Gabríel Steg; Marco Valgimigli; Stephan Windecker; Pascal Vranckx; Patrick W. Serruys

doi:10.4244/eij-d-21-00870

Related publications

Article2019

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Patrick W. Serruys, Mariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, Norihiro Kogame, Kuniaki Takahashi, Chun Chin Chang, Ernest Spitzer, Simon Walsh, David Adlam, David Hildick‐Smith, István Édes, Pim van de Harst, Florian Krackhardt, Jan G.P. Tijssen, Tessa Rademaker‐Havinga, Scot Garg, Philippe Gabríel Steg, Christian W. Hamm, Peter Jüni, Pascal Vranckx, Yoshinobu Onuma, Freek W.A. Verheugt

EuroIntervention

Article2025

Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trial

Caio de Assis Moura Tavares, Patrícia O. Guimarães, Marcelo Franken, Karla Santo, Guy F. A. Prado, Felipe Bezerra, Vagner Madrini, Willterson Carlos Bandeira, G S Délcio, Gabriela Montenegro, J Forte, Walter Alvarenga, Fernando De Martino, Marcos Mitsuo Seki, José Francisco Kerr Saraiva, J Saad, Adriano Caixeta, João Luiz de Alencar Araripe Falcão, Weimar Kunz Sebba Barroso, George César Ximenes Meireles, Thiago Braido Dias,

Article2020

Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS trial

Felice Gragnano, Marcel Zwahlen, P Vranckx, Peter Jüni, Dik Heg, Christian W. Hamm, Philippe Gabríel Steg, Niels Hagenbuch, Giuseppe Gargiulo, Robert‐Jan van Geuns, Kurt Huber, Ronald van Amsterdam, Patrick W. Serruys, Marco Valgimigli, Stephan Windecker

European Heart Journal

Article2019

Clinical relevance of ticagrelor monotherapy following 1‐month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial

Norihiro Kogame, Ply Chichareon, Kenneth De Wilder, Kuniaki Takahashi, Rodrigo Modolo, Chun Chin Chang, Mariusz Tomaniak, Hidenori Komiyama, Alaide Chieffo, Antonio Colombo, Scot Garg, Yves Louvard, Peter Jüni, Philippe Gabríel Steg, Christian W. Hamm, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, Hans‐Peter Stoll, Yoshinobu Onuma, Luc Janssens,

Article2022

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, Dik Heg, Kurt Schmidlin, Christian W. Hamm, Philippe Gabríel Steg, Giuseppe Gargiulo, Eugène McFadden, Yoshinobu Onuma, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Sergio Leonardi, Aleksander Żurakowski, Alessio Arrivi, Robert‐Jan van Geuns, Kurt Huber, Ton Slagboom, Paolo Calabrò, Patrick W. Serruys,